An inhibitor of mutant EGFR
Technical Support & Resources

Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

Pebezertinib

Item No. 46564

Technical Information
Formal Name
N-[4-fluoro-3-[[2-[(1-methyl-1H-pyrazol-4-yl)amino]-5-[4-(trifluoromethyl)phenyl]-4-pyrimidinyl]amino]phenyl]-2-propenamide
CAS Number
2769954-39-2
Synonyms
  • BLU-451
  • LNG-451
Molecular Formula
C24H19F4N7O
Formula Weight
Purity
≥95%
A solid
DMSO: Sparingly soluble: 1-10 mg/ml
SMILES
CN1N=CC(NC2=NC(NC3=CC(NC(C=C)=O)=CC=C3F)=C(C=N2)C(C=C4)=CC=C4C(F)(F)F)=C1
InChi Code
InChI=1S/C24H19F4N7O/c1-3-21(36)31-16-8-9-19(25)20(10-16)33-22-18(14-4-6-15(7-5-14)24(26,27)28)12-29-23(34-22)32-17-11-30-35(2)13-17/h3-13H,1H2,2H3,(H,31,36)(H2,29,32,33,34)
InChi Key
XIMJCWSFLXXQMZ-UHFFFAOYSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Add

    Add

    Kinase Resource Center
    Discover Products & Resources for Kinase Research
    • Kinase inhibitors, screening libraries, assay kits, & more
    • Tools to study kinase signaling pathways:
      • Growth factor signaling
      • PI3K/Akt/mTOR
      • MAPKs (ERK, p38, & JNK)
      • JAK/STAT signaling
    • Articles, resources, & advice
    EXPLORE NOW
    Product Description

    Pebezertinib is a covalent inhibitor of mutant EGFR.1 It selectively inhibits EGFRL858R, EGFR containing an exon 19 deletion (ex19del), and EGFR containing the exon 20 insertion D770insNGP (EGFRD770insNGP) over wild-type EGFR (IC50s = 3.4, 3, 8.6, and 81 nM, respectively). Pebezertinib reduces EGFR phosphorylation in, and the proliferation of, Ba/F3 cells expressing various EGFR mutations but does not reduce the proliferation of A431 cells, which express wild-type EGFR. It reduces tumor size in patient-derived xenograft (PDX) mouse models of non-small cell lung cancer (NSCLC) with cells expressing EGFRH773insNPH or EGFRV769insASV. Pebezertinib (2.5-25 mg/kg, p.o) reduces tumor size in a PC-9 NSCLC mouse xenograft model of metastatic brain cancer.

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Millet, Y.A., Spira, A.I., Baik, C.S., et al. BLU-451, a CNS-active, potent, and selective small-molecule inhibitor against uncommon EGFR mutations. Mol. Cancer Ther. (2026).